Risk Prediction, Diagnosis and Management of a Breast Cancer Patient with Treatment-Related Cardiovascular Toxicity: An Essential Overview.
Michael CroninAoife LoweryMichael KerinWilliam WijnsJuan Carlos ParodiPublished in: Cancers (2024)
Breast cancer is amongst the most common invasive cancers in adults. There are established relationships between anti-cancer treatments for breast cancer and cardiovascular side effects. In recent years, novel anti-cancer treatments have been established, as well as the availability of multi-modal cardiac imaging and the sophistication of treatment for cardiac disease. This review provides an in-depth overview regarding the interface of breast cancer and cancer therapy-related cardiovascular toxicity. Specifically, it reviews the pathophysiology of breast cancer, the method of action in therapy-related cardiovascular toxicity from anti-cancer treatment, the use of echocardiography, cardiac CT, MRI, or nuclear medicine as diagnostics, and the current evidence-based treatments available. It is intended to be an all-encompassing review for clinicians caring for patients in this situation.
Keyphrases
- left ventricular
- cancer therapy
- oxidative stress
- end stage renal disease
- newly diagnosed
- magnetic resonance imaging
- chronic kidney disease
- ejection fraction
- stem cells
- randomized controlled trial
- high resolution
- pulmonary hypertension
- systematic review
- case report
- palliative care
- magnetic resonance
- peritoneal dialysis
- mass spectrometry
- optical coherence tomography
- image quality
- replacement therapy